In the Report “Bioinformatics Market: By Products (Bioinformatics Platforms, Knowledge Management Tools, Services), By Applications (Genomics, Proteomics, Transcriptomics, Metabolomics, Molecular Phylogenetics, Chemoinformatics & Drug Design, Others), By Sector (Drug Development, Clinical Diagnostics, Gene Therapy) - With Forecast (2018-2023)” published by IndustryARC, the market is driven by drug discovery and development of personalized medicines and clinical diagnostics.
America with major share in the Bioinformatics Market:
The American region has seen substantial inflow of investment in the bioinformatics sector and as a result,has seen various advancements and rapid growth in demand for the market. China, sustained by its investment in life sciences, has also seen similar growth.But most of its services are off-shore rather than its onshore products for bio-informatics.
Middle East and Africa are among the least opportunistic for the market as the need for bio-informatics is still at its burgeoning stages. Approximately 34% of bioinformatics market is used for services such as sequencing, data analysis and database management, with 50% used in bioinformatics platform markets. The market for bioinformatics is buoyant, with increasing demand in Asia.
Bioinformatics Market Analysis done in the full Report:
The Bioinformatics platform offers services that include database design, software engineering and data integration.The sequence analysis is the procedure of subjecting a DNA, RNA or peptide sequence to extensive variety of analytical tools to comprehend its features, function, structure, or evolution. The sequencing finds its use in various applications such as molecular biology, evolutionary biology, metagenomics, medicine, forensic and more. The Bioinformatics platform is anticipated to grow at a CAGR of 19.9% and will reach revenue of $10.91 billion by 2023.
The next product is Knowledge Management tool, which delivers strategy, process and technology.This helps influencing information and knowledge that will escalate the level of understanding which will enhance the problem solving and decision making quality. The bioinformatics knowledge management market is estimated to reach $3.18 billion by 2023. Similarly, next generation sequencing service is the future trend in the market. It possesses various characteristics that are different from other sequencing techniques such as much shorter reads (25-300 bp), higher throughput, lower cost per MB, single molecular sequencing and more. The bioinformatics services market is anticipated to grow at a CAGR of 22.9% and to reach revenue of $9.15 billion by 2023. This market is all set to experience a booming trend owing to the Increase in demand for biology modeling, which is driven by large-scale integration in the drug discovery process.
To access / purchase the full report browse the link below
https://industryarc.com/Report/10631/bioinformatics-market-analysis.html
Excerpts on Market Growth Factors:
• The survey of sequence and protein structure information has led to the explosive growth of bioinformatics in the last decade. The discipline is becoming increasingly important in the study of biomedical problems and will perhaps continue till the forecast.
• Unavailability of efficient drugs, and the high cost associated is the major reason behind most deaths. Development of cheap and efficient drugs for a disease is one of the major problems faced by mankind. Bioinformatics will be a major solution to this problem for the development of rational drug design.
• Recent advances in clinical diagnostics in biological sciences and systems have created a tremendous amount of bioinformatics related data. Bioinformatics tools have been developed to exploit the wealth of information and transform it into useful knowledge including data mining techniques, aiming to discover hidden knowledge.
• Current chemical advancement for drug discovery are generating chemical data in large scale which is denoted as information explosion that has built a demand for effective collection, organization, analysis and application ofthe chemical information in the process of modern drug discovery and development.
Key players of the Bioinformatics Industry:
The company has carried out various major acquisitions which contributed to the positive growth of the market. Illumina Inc., Qiagen NV, Thermo Fisher Scientific Inc., DNAnexus, BioMax, Perkin Elmer and others are some of the role playing companies. The large number of market players operating in the global bioinformatics industry is investing in research and development projects. They are also looking forward towards technological advances for increasing applications in biosciences and integrated information technology.
Bioinformatics Marketreport is segmented as below:
The Global Bioinformatics Marketstudy across various end user industries is incorporated in the report.
A. Bioinformatics Market – By Products
1. Bioinformatics Platforms
2. Knowledge Management Tools
3. Services
B. Bioinformatics Market – By Applications
1. Genomics
2. Proteomics
3. Transcriptomics
4. Metabolomics
5. Molecular Phylogenetics
6. Chemoinformatics & Drug Design
7. Others
C. Bioinformatics Market – By Sector
1. Medical bioinformatics
2. Drug Development
3. Clinical Diagnostics
4. Molecular Medicine
5. Gene Therapy
6. Reproductive Biotechnology
7. Animal Bioinformatics
8. Agricultural Bioinformatics
9. Environmental Bioinformatics
10. Forensic Bioinformatics
11. Academics
12. Others
D. Bioinformatics Market by Geography (covers 10+ countries)
E. Bioinformatics MarketEntropy
Companies Citied / Interviewed
1. Agilent Technologies Inc.
2. ID Business Solutions Ltd.
3. Dassault Systemes Biovia Corp
4. Bruker Corporation
5. Applied Biological Materials (ABM)
6. Waters Corporation
7. PerkinElmer, Inc.
8. Company 8
9. Company 9
10. Company 10+
Related Report:
A. Genomics Market
https://industryarc.com/Report/1275/genomics-market-analysis-and-forecast-report.html
B. Synthetic Biology Market
https://industryarc.com/Report/15142/synthetic-biology-market.html
What can you expect from the report?
The Bioinformatics MarketReport is Prepared with the Main Agenda to Cover the following 20 points:
1. Market Size by Product Categories & Application 11. Demand Analysis (Revenue & Volume)
2. Market trends & Relevant Market Data 12. Country level Analysis
3. Manufacturer Landscape 13. Competitor Analysis
4. Distributor Landscape 14. Market Shares Analysis
5. Pricing Analysis 15. Value Chain Analysis
6. Top 10 End user Analysis 16. Supply Chain Analysis
7. Product Benchmarking 17. Strategic Analysis
8. Product Developments 18. Current & Future Market Landscape Analysis
9. Mergers & Acquisition Analysis 19. Opportunity Analysis
10. Patent Analysis 20. Revenue and Volume Analysis
Frequently Asked Questions:
Q. Does IndustryARC provide customized reports and charge additionally for limited customization?
Response:Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:
1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interests.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.
Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
Media Contact:
Mr. Venkat Reddy
Sales Manager
Email 1: [email protected]
Or Email 2: [email protected]
Contact Sales: +1-614-588-8538 (Ext-101)
About IndustryARC:
IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences &Healthcare.
IndustryARC primarily focuses on cutting-edge technologies and newer applications in a market. Our custom research services are designed to provide insights on the constant flux in the global supply–demand gap of markets. Our strong team of analysts enables us to meet the client’s research needs at a rapid speed and with a variety of options.
We look forward to helping the client address its customer needs effectively, stay ahead in the market, become the top competitor, and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.
Bioinformatics Market anticipated to grow at a CAGR of 20.83% and to reach $22.46B by 2023.
Bioinformatics Market SizeBioinformatics Market is estimated to grow from USD 8.15 Billion in 2019 to reach USD 24.51 Billion by 2027, at a CAGR of 14.8% during the forecast period from 2020-2027.Increasing research and development activities for protein and nucleic acid sequencing as a result of technological advancements and cost reduction, growth in use of bioinformatics tools in large number of applications such as personalized medicines, clinical diagnostics, drug discovery, proteomics etc.
and favorable government funds/grants for bioinformatics research, increasing numbers of strategic ollaborations between research institutes and biopharmaceutical companies are factors driving the growth of bioinformatics market.Request for Sample Report: https://www.reportcrux.com/request-sample-report/Bioinformatics-MarketBioinformatics CompaniesHere are 13 of the best Bioinformatics Companies analysis• Eurofins Scientific• Thermo Fisher Scientific• Illumina• Qiagen Bioinformatics• Perkinelmer, Inc.• Agilent Technologies• Waters Corporation• Dnasta• Sophia Genetics• Biomax Informatics AG• Partek• Beijing Genomics Institute (BGI)• Wuxi Nextcode among othersMarket OverviewThe market report covers a basic overview of the market from the industry perspective.
This will help the reader to get a gist about different industry dimensions from a manufacturer’s view.
The report divides the market into different sections and is comprised of market revenue (value) by segments.The report provides market data from 2016 till 2027, wherein, 2016 to 2018 will be historic years, 2019 would be the base year and 2020 to 2027 will be forecast years.
The report provides different statistics and figures and charts that will help analyze trends and global Bioinformatics market share along with its growth rate in different regions and countries.Key players across the globe are profiled in the report along with its company landscaping.
Product portfolio for each company, recent developments and company strategies are covered along with the company financials.Various drivers, restraints and opportunities in the Bioinformatics market are analyzed in detail in the report.
Bioinformatics is the application of computer technology for the management and analysis of biological data.
It includes collection, storage, retrieval, manipulation, and modelling of data for analysis, visualization, or prediction through algorithms and software.
The global bioinformatics market is expected to account for USD 7,063.7 billion in 2018.
It is expected to reach USD 13,901.5 billion by 2023, at a CAGR of 14.5% during the forecast period.Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39By Product and Services, bioinformatics platforms segment is expected to be the fastest-growing segment in the forecast periodKnowledge management tools commanded the largest market share in the global bioinformatics market in 2018, while the bioinformatics platforms segment is expected to be the fastest-growing segment in the forecast period.
The major factor driving growth of bioinformatics platforms is their growing use in various genomic applications.By Application, the metabolomics segment is expected to grow at the highest CAGR during the forecast periodFactors such as the availability of research funding and government support are fueling market growth.
However, metabolomes cannot be easily identified or figured from reconstructed biochemical pathways due to enzymatic diversity, substrate ambiguity, and difference in regulatory mechanisms.
Bioinformatics Market SizeBioinformatics Market is estimated to grow from USD 8.15 Billion in 2019 to reach USD 24.51 Billion by 2027, at a CAGR of 14.8% during the forecast period from 2020-2027.Increasing research and development activities for protein and nucleic acid sequencing as a result of technological advancements and cost reduction, growth in use of bioinformatics tools in large number of applications such as personalized medicines, clinical diagnostics, drug discovery, proteomics etc.
and favorable government funds/grants for bioinformatics research, increasing numbers of strategic ollaborations between research institutes and biopharmaceutical companies are factors driving the growth of bioinformatics market.Request for Sample Report: https://www.reportcrux.com/request-sample-report/Bioinformatics-MarketBioinformatics CompaniesHere are 13 of the best Bioinformatics Companies analysis• Eurofins Scientific• Thermo Fisher Scientific• Illumina• Qiagen Bioinformatics• Perkinelmer, Inc.• Agilent Technologies• Waters Corporation• Dnasta• Sophia Genetics• Biomax Informatics AG• Partek• Beijing Genomics Institute (BGI)• Wuxi Nextcode among othersMarket OverviewThe market report covers a basic overview of the market from the industry perspective.
This will help the reader to get a gist about different industry dimensions from a manufacturer’s view.
The report divides the market into different sections and is comprised of market revenue (value) by segments.The report provides market data from 2016 till 2027, wherein, 2016 to 2018 will be historic years, 2019 would be the base year and 2020 to 2027 will be forecast years.
The report provides different statistics and figures and charts that will help analyze trends and global Bioinformatics market share along with its growth rate in different regions and countries.Key players across the globe are profiled in the report along with its company landscaping.
Product portfolio for each company, recent developments and company strategies are covered along with the company financials.Various drivers, restraints and opportunities in the Bioinformatics market are analyzed in detail in the report.
Bioinformatics is the application of computer technology for the management and analysis of biological data.
It includes collection, storage, retrieval, manipulation, and modelling of data for analysis, visualization, or prediction through algorithms and software.
The global bioinformatics market is expected to account for USD 7,063.7 billion in 2018.
It is expected to reach USD 13,901.5 billion by 2023, at a CAGR of 14.5% during the forecast period.Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39By Product and Services, bioinformatics platforms segment is expected to be the fastest-growing segment in the forecast periodKnowledge management tools commanded the largest market share in the global bioinformatics market in 2018, while the bioinformatics platforms segment is expected to be the fastest-growing segment in the forecast period.
The major factor driving growth of bioinformatics platforms is their growing use in various genomic applications.By Application, the metabolomics segment is expected to grow at the highest CAGR during the forecast periodFactors such as the availability of research funding and government support are fueling market growth.
However, metabolomes cannot be easily identified or figured from reconstructed biochemical pathways due to enzymatic diversity, substrate ambiguity, and difference in regulatory mechanisms.